In conclusion, this is the first study providing proof of the anti-epileptic potential of P2X7R antagonism using a human model system and suggests P2X7Rs-based treatments as novel adjunctive therapy for drug-refractory epilepsy.

AUTHOR CONTRIBUTIONS